Back on July 24, BioWorld took a look at how, “Boosted by COVID-19 success, Taiwan life sciences sector building government, investor support.” After no COVID-19 cases for 100 days, Taiwan looks like a success and, “has drawn attention to its medical achievements.”...
Asia
Category
Chinese University of Hong Kong Research: Severity of COVID-19 Impact Associated with Lack of Face Mask Usage
Researchers working out of the Chinese University of Hong Kong recently disclosed findings from an analysis the correlation of public interest in face masks and the severity of COVID-19 outbreaks. Furthermore, face mask usage may be associated with the containment of...
Asian Regional CRO Reports Record Setting Study Startup Times for Clinical Trials; An Ongoing Response to Pandemic or a New Industry Benchmark?
One of Asia-Pacific’s largest regional contract research organizations (CRO) called Novotech, reports that many countries are fast-tracking their COVID-19 clients’ clinical trials with expedited review processes for treatment and vaccine candidates. In fact,...
Taipei Medical University (TMU) to Open New Taipei Cancer Center & Add to Robust Clinical Trials Site Infrastructure
Taipei Medical University (TMU), funding the Taipei Cancer Center, is expected to complete construction before the end of 2020 to be in business for patients shortly thereafter. This new state-of-the-art cancer center in Taiwan will introduce proton therapy, a type of...
Asian Hospital Chain Columbia Asia Moving into the World of Clinical Investigational Site Participation with TriNetX
TrialSite News has profiled TriNetX, the global health research network that purports to revolutionize clinical research through the generation of real-world evidence (RWE) and its Asian expansion with the addition of 11 hospitals from Columbia Asia, an international...
European Biotechs Head to Asia to Conduct Their Clinical Trials in Greater Numbers
Asia-Pacific countries are becoming the new hub for clinical trials, luring biotech sponsors from Europe, and even America, to conduct research in the Far East. Since 2016, Asia’s clinical trial activity increases by 26% per year. A number of factors are involved...
Asia-focused Non-Invasive Colon Detection Technology to be Commercialized by Alibaba-backed Digital Health Venture
New Horizon Health Limited, a vendor in China that focuses on non-invasive colon cancer screening technology, inked an exclusive deal with Prenetics Limited, a genetics and digital health company in Asia and Europe. New Horizon will undertake a technology transfer to...
Korean Academic Research Centers Develop Vaccine for Deadly Tick-Born Asian-Based Virus
The Korea Advanced Institute of Science and Technology (KAIST) and Chungbuk National University College of Medicine (CNUCM) has developed a vaccine for Asian-based Huaiyangshan banyangvirus, also known as severe fever with thrombocytopenia syndrome (SFTS) virus...
Taiwan Provider Shares Expertise with Peers in Thailand
Changhua Christian Hospital seeks to share the medical expertise, personnel and technological advantages of Taiwan’s health care system with Thailand. The Ministry of Health and Welfare of Taiwan announced a “one country, one hospital” policy in a recent press...
Taiwan Researchers Connect Hidradenitis Suppurativa & Cardiovascular & Metabolic Risk
A prominent group of clinical investigators from Taiwan has produced a nationwide, population-based cohort study evidencing the association of Hidradenitis Suppurativa (HS) and metabolic syndrome and coronary artery disease. A nationwide-level study in Asia, however,...
Skin Research Institute Singapore & NovoTech CRO Ink Partnership
Australian-based, Asia-Pacific focused CRO Novotech has formed a partnership with the Skin Research Institute of Singapore (SRIS) to enhance quality research opportunities in Asia. Skin Research Institute of Singapore (SRIS) SRIS was established as a collaboration...
Korean-based Alteogen Secures access to China for its Herceptin Biosimilar
Korean-based Alteogen reports that China’s Qilu Pharmaceutical has received IND approval for ALT-02, a Herceptin biosimilar, from the China Food and Drug Administration. What is the Connection between Alteogen license and Qilu Pharmaceutical? The Korean company...
Lung Cancer Rates Rising Across Asia
Of the 1.8 million killed by lung cancer worldwide in 2018, 61.4% passed in the Asia Pacific region according to a recent report. 59.% of the world’s new lung cancer cases are found in the same region. Across ASEAN member states, lung cancer recorded a total of...
Clinical Trials in the Indonesian Archipelago: Enter the Pristine Waters Slowly and Carefully
With nearly 270 million people Indonesia is the 4th most populous country. Incredibly diversified in every way—from people, language and culture to geography and geology to history--this southeast Asian archipelago includes nearly 300 languages, a growing demand for...
Asian Drug Development Market Open Up About China’s Regulatory Transformation
China’s drug development regulatory environment going through “sea changes” and Korean drugmakers need to capitalize on the window of opportunity experts reported at recent clinical trials and China regulatory forum in Seoul, Korea. The forum organized by Korea...
Cream of the Crop in Asia: Top Asian Universities Among the Global Pack
Asia generally continues to grow in prowess in education, evidenced by the latest QS World University Rankings 2020, which are testimony to the region’s commitment to academic excellence. Of course, clinical research benefits from this growing stature. A total of 12...
George Clinical Expanding into Taiwan
George Clinical, an Australian-based, global, scientifically-backed clinical research organization (CRO) has significantly expanded its capabilities in Taiwan, having been granted a license to import drugs into the country for clinical trials on behalf of sponsors. ...
CRO Novotech Deepens Partners with South Korean Clinical Sites
Novotech, Australia’s largest independent CRO, reports it has enhanced its strength in South Korea; it's inking alliances with two major hospitals and opening up a rich, investigator network, key opinion leaders and up to 4 million patients. What assets does this...
Veeda Clinical Achieves Successful Malaysian Agency Inspection
Veeda Clinical, an Asian mid-market CRO, reports it has successfully cleared 60 regulatory audits in the last 14 months, including 19 USFDA inspections of its facilities and clinical trial sites in last 24 months. Its clinical facility is in Shivalik, Ahmedabad and...
Shionogi & Akili to Commercialize Digital Therapeutics in Asian Markets
Japan-based Shionogi & Co., Ltd. (Shionogi) has formed a strategic alliance with digital therapy venture Akili to develop and commercialize digital therapeutics in Asia. The two report in a joint press release that Akili will create first-of-its-kind...